GLP-1 · Dual-Action
Tirzepatide
Dual-action potency for accelerated, physician-managed results — titrated and reviewed individually, with flat-rate pricing.
Available by consultation
Clinical Overview
How Tirzepatide works
A weekly dual agonist that activates two metabolic pathways — GIP and GLP-1 — for deeper appetite control and stronger results.
Engages the GIP receptor
Targets glucose-dependent insulinotropic polypeptide — a metabolic pathway most weight-management medications do not address.
Engages the GLP-1 receptor
Simultaneously mimics GLP-1 — suppressing appetite and slowing how quickly food leaves the stomach.
Combined metabolic effect
The dual mechanism produces the highest average weight loss recorded in any GLP-1-class clinical trial to date.
Candidacy Profiling
A considered fit, not a funnel.
A considered fit, not a funnel. Tirzepatide suits men ready for the most advanced GLP-1-class protocol, with the supervision and titration discipline it requires.
- Adults 18+ with a BMI of 27 or higher, or 25+ with weight-related conditions
- Patients who want a plan reviewed individually, not a one-size prescription
- Members set on steady, monitored progress over months
- Personal or family history of medullary thyroid carcinoma or MEN 2
- Pregnancy, breastfeeding, or planning pregnancy
- Active pancreatitis or untreated severe gastrointestinal disease
Expected Timeline
What to expect
Tirzepatide tends to act faster and reach further than single-agonist GLP-1s. Your physician titrates carefully to the dose that fits your body.
- 01
Month 1
Titration
A low starting dose is introduced as your body adjusts.
- 02
Month 3
Established
Therapeutic dose reached. Appetite control deepens and progress accelerates.
- 03
Month 6
~21%
Average body-weight reduction reported in published tirzepatide trials.
- 04
Year 1+
Maintained
Results sustained with ongoing physician-guided treatment.
Outcomes referenced from SURMOUNT trial data. Individual results depend on starting weight, dose, and adherence.
Your Concierge Support
A licensed clinician, matched to you.
Kraton Rx is powered by licensed U.S. physicians who specialize in men's weight loss, peptide therapy, and longevity. Every patient is reviewed individually, prescribed only when clinically appropriate, and given direct, secure messaging access to their care team throughout the journey.
- 01Compounded medication
- Prepared by licensed U.S. compounding pharmacies and shipped on a structured cadence.
- 02Physician-guided care
- Every interaction is guided by our licensed care team — not a rotating call center.
- 03Physician-managed dosing
- Titration and adjustments at every transition, reviewed individually.
- 04Direct message access
- Reach your care team between check-ins through your secure patient portal.
- 05Structured check-ins
- Cadenced reviews that keep your protocol tuned to your response.
- 06Discreet delivery
- Temperature-controlled, unmarked packaging delivered to your door.
The Kraton standard
Physician-led care, reviewed individually — never a one-size prescription.
- 01.Physician-Led
- Every protocol is designed and personally approved by a licensed U.S. physician — prescribed only when it's clinically appropriate for you.
- 02.Reviewed Individually
- No funnels, no vending-machine scripts. Your health profile is reviewed one patient at a time and your plan is titrated to you.
- 03.Delivered Discreetly
- Care arrives in private, unbranded packaging, with your care team a secure message away through the whole journey.
Clinical Safety
No medication is right for everyone.
Common side effects
Most common during titration: nausea, decreased appetite, and digestive changes. Typically mild and resolve as the body adjusts to each step in the protocol.
Clinical Contraindications
Not appropriate for patients with a personal or family history of medullary thyroid carcinoma or MEN 2, or for patients who are pregnant or breastfeeding. Full medical history is reviewed before any prescription is authorized.
Kraton Rx protocols are prepared by licensed U.S. compounding pharmacies. Compounding pharmacies are regulated by both state boards and the FDA and have been part of American medicine for generations. The active ingredient is prepared per your protocol — supervised by your physician — and delivered discreetly to your door.
Clinical Experience
From members of the Tirzepatide program.
- “
I'd plateaued for months. Switching to Tirzepatide under my physician was a second wind — another 24 pounds down and my labs are the best they've been in a decade.
- “
The speed surprised me. By week three I was setting reminders to eat. Energy is up, focus is up, and every adjustment was walked through with me.
- “
Discreet packaging, secure messaging, real physician oversight. It's the most serious my health has ever been taken — and the easiest.
Frequently Asked
Questions worth asking before you begin.
Yes. Every protocol is reviewed by a licensed U.S. physician and prescribed only when clinically appropriate.
Entirely. Kraton Rx uses telehealth for intake, physician review, and ongoing follow-up — no waiting room.
Always. Your information is protected, and treatments ship in private, unbranded packaging to your door.
Our programs feature flat-rate pricing with no hidden fees, no consultation charges, and no dose-change surcharges. The price we quote is the price you pay.
Memberships may be canceled with 30 days' notice prior to the next billing cycle. Consultations, medical visits, and fulfilled prescriptions are non-refundable once services begin or medication is processed.
Yes. Kraton Rx is HIPAA compliant. Your medical information is shared only with your assigned physician and the dispensing pharmacy. We never sell or share your data.
Comparison Protocol
Semaglutide
The foundational single-agonist GLP-1. Lower trial averages, often the right starting point.
Begin Consultation
The Tirzepatide program begins with a conversation.
Your consultation is reviewed by your dedicated provider. If authorized, your protocol is prepared by a partner compounding pharmacy and delivered direct to your door.